Results 171 to 180 of about 69,478 (239)

Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>. [PDF]

Open Forum Infect Dis
Bhavnani SM, Hammel JP, Onufrak NJ, Pogue JM, Jones RN, Sader HS, Drusano GL, Bradley JS, Andes DR, Craig WA, Ambrose PG.   +10 more
europepmc   +1 more source

Glycan-binding properties of SARS-CoV-2 spike proteins: interactions with aminoglycoside antibiotics. [PDF]

Sci Rep
Hatakeyama D, Shoji M, Miki Y, Ueki S, Yamaguchi K, Nakashima K, Tanaka Y, Yokogawa M, Osawa M, Kasai Y, Imagawa H, Hashimoto R, Takayama K, Kuzuhara T.   +13 more
europepmc   +1 more source

Development of a predictive model using automated machine learning for Carbapenem-resistant Organisms (CRO) infections in hospitalized patients. [PDF]

Front Microbiol
Fang D, Shi R.
europepmc   +1 more source

Cyclitols and Aminocyclitols as Signals: Their Roles in Supporting Ecosystems and Promoting Human Health. [PDF]

J Nat Prod
Skala L, Murdach PK, Hennelly T, Mahmud T.   +3 more
europepmc   +1 more source

Acquired resistance in Stenotrophomonas maltophilia: Mechanisms underlying the shift from multidrug to pandrug resistance. [PDF]

Eur J Microbiol Immunol (Bp)
Vattanaviboon P, Dulyayangkul P, Tipanyo P, Mongkolsuk S, Charoenlap N.   +4 more
europepmc   +1 more source

Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection model. [PDF]

Antimicrob Agents Chemother
Singh N, Jogan CML, Zang Y, Shan X, Lang Y, Karunanidhi A, Watkins JV, Curry BN, Tamma PD, Nozick SH, Ozer EA, Hauser AR, Bulitta JB, Bulman ZP.   +13 more
europepmc   +1 more source